Equitable Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
14,241
+226
| +2% | +$19.9K | 0.01% | 731 |
|
|
2025
Q1 | $1.28M | Sell |
14,015
-1,649
| -11% | -$150K | 0.01% | 637 |
|
|
2024
Q4 | $1.35M | Sell |
15,664
-8,494
| -35% | -$733K | 0.01% | 592 |
|
|
2024
Q3 | $2.3M | Buy |
24,158
+2,221
| +10% | +$211K | 0.02% | 455 |
|
|
2024
Q2 | $2.01M | Buy |
21,937
+874
| +4% | +$80K | 0.02% | 457 |
|
|
2024
Q1 | $1.91M | Sell |
21,063
-7,072
| -25% | -$641K | 0.02% | 455 |
|
|
2023
Q4 | $2.29M | Buy |
28,135
+7,485
| +36% | +$609K | 0.03% | 382 |
|
|
2023
Q3 | $1.65M | Buy |
20,650
+10,940
| +113% | +$874K | 0.02% | 419 |
|
|
2023
Q2 | $765K | Buy |
9,710
+4,261
| +78% | +$336K | 0.01% | 589 |
|
|
2023
Q1 | $423K | Buy |
5,449
+736
| +16% | +$57.1K | 0.01% | 687 |
|
|
2022
Q4 | $366K | Buy |
4,713
+1,420
| +43% | +$110K | 0.01% | 686 |
|
|
2022
Q3 | $221K | Buy |
3,293
+145
| +5% | +$9.73K | ﹤0.01% | 775 |
|
|
2022
Q2 | $242K | Buy |
3,148
+158
| +5% | +$12.1K | ﹤0.01% | 759 |
|
|
2022
Q1 | $238K | Buy |
+2,990
| New | +$238K | ﹤0.01% | 788 |
|